Investors Buy Large Volume of AbbVie Put Options (ABBV)
Shares of AbbVie (NASDAQ:ABBV) saw unusually large options trading activity on Monday. Stock investors bought 6,892 put options on the stock, American Banking & Market News reports. This represents an increase of approximately 711% compared to the average daily volume of 850 put options.
A number of research firms have recently commented on ABBV. Analysts at Jefferies Group raised their price target on shares of AbbVie from $66.00 to $71.00 in a research note on Monday. They now have a “buy” rating on the stock. Separately, analysts at Barclays upgraded shares of AbbVie from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, July 2nd. They now have a $69.00 price target on the stock, up previously from $44.00. Finally, analysts at Argus raised their price target on shares of AbbVie from $59.00 to $65.00 in a research note on Tuesday, June 24th. They now have a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. AbbVie presently has a consensus rating of “Buy” and an average target price of $60.00.
Shares of AbbVie (NASDAQ:ABBV) traded down 0.20% on Monday, hitting $54.85. The stock had a trading volume of 30,823,346 shares. AbbVie has a 52-week low of $42.25 and a 52-week high of $58.27. The stock’s 50-day moving average is $54.94 and its 200-day moving average is $51.85. The company has a market cap of $87.215 billion and a price-to-earnings ratio of 21.39.
AbbVie (NASDAQ:ABBV) last released its earnings data on Friday, April 25th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.03. The company had revenue of $4.56 billion for the quarter, compared to the consensus estimate of $4.33 billion. During the same quarter in the previous year, the company posted $0.68 earnings per share. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. Analysts expect that AbbVie will post $3.15 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, August 15th. Stockholders of record on Tuesday, July 15th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 3.06%. The ex-dividend date of this dividend is Friday, July 11th.
AbbVie Inc (NASDAQ:ABBV) is a research-based pharmaceuticals company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.